1. All Products
  2. DORAHALP - Haloperidol
  3. HALOPERIDOL, 1.5mg, tab.
Public Pricelist

HALOPERIDOL, 1.5mg, tab.

https://medicalguidelines.msf.org/en/node/415
https://unicat.msf.org/cat/product/86731
STD DORAHALP15T

Valid Article

2.3 - Medicines for other common symptoms in palliative care
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
24.1 - Medicines for psychotic disorders
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N05AD01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

HALOPERIDOL

Therapeutic Action

Antipsychotic (neuroleptic)

Indications

Acute confusional state (delirium) and acute alcohol intoxication

Acute or chronic psychosis

Acute moderate to severe manic episode

Agitation or aggressive behaviour in patients with acute or chronic psychosis, in association with promethazine

Instructions for use

It is recommended to order biperiden (or trihexyphenidyl) together with haloperidol, to be given in the event of extrapyramidal disorders.

In some countries, haloperidol is on the list of narcotics: follow national regulations (Cf Introduction: Narcotic and psychotropic medicines under international control)

Precautions for Use

Do not administer in patients with cardiac disorders, dementia, Parkinson's disease and history of neuroleptic malignant syndrome.

Administer with caution and carefully monitor use in elderly patients and patients with hypokalaemia, hypotension, prostate disorders, renal or hepatic impairment, history of seizures.

Storage

Below 25°C